Is India Winning the War Against Rising Non-Communicable Diseases? The latest health statistics paint a concerning picture: diabetes, heart disease, and cancer rates are climbing, impacting millions across the country. From rural healthcare access to the burgeoning urban health crisis, challenges remain significant. This week, we delve into the crucial initiatives underway – government policies, technological advancements in telemedicine, and the rising role of preventative healthcare – that aim to address this national health emergency. Experts weigh in on the effectiveness of current strategies and the critical need for increased public awareness campaigns targeting lifestyle diseases. Are these efforts enough? Explore Abtak.com's in-depth coverage on healthcare in India and discover the vital information you need to protect your well-being and the future of public health. Stay informed; stay healthy.
New Delhi, India - The quest for thicker, healthier hair has led many down a path of serums, supplements, and even surgical procedures. But a cutting-edge treatment utilizing microscopic "bubbles" called exosomes is emerging as a potential game-changer. Exosomes are tiny vesicles released by cells, acting as messengers carrying proteins and genetic material to other cells. This natural interaction system has sparked interest in the field of regenerative medicine, with exosome therapy showing promise for a range of applications, including hair and skin rejuvenation. "Exosomes are like tiny packages of goodness," explains Dr.Priya Sharma, a leading dermatologist in New Delhi. "They can deliver growth factors and other beneficial molecules directly to hair follicles, potentially stimulating hair growth and improving hair quality." While still in its early stages in India, exosome therapy is gaining traction among patients seeking non-invasive solutions for hair loss. The treatment typically involves injecting a concentrated solution of exosomes derived from the patient's own cells into the scalp. "The idea of using my own cells to promote hair growth is very appealing," says Amit Kapoor, a 35-year-old patient who recently underwent exosome therapy. "I'm hopeful that this treatment will help me regain some of the hair I've lost." While early results are encouraging, more research is needed to fully understand the long-term efficacy and safety of exosome therapy for hair loss. however, the potential of this innovative treatment has sparked excitement among both patients and medical professionals. "Exosome therapy represents a paradigm shift in hair restoration," says Dr. Sharma. "It harnesses the body's own healing mechanisms to promote natural hair growth, offering a potentially safer and more effective alternative to traditional treatments." Scientists are exploring innovative approaches to combat hair loss, moving beyond single therapies and towards a multi-pronged attack. For millions of Americans, hair loss is a frustrating and often emotionally distressing experience. While treatments like minoxidil and finasteride offer some relief, they don't work for everyone and often come with side effects.Now, researchers are investigating a new frontier in hair regrowth: combining existing therapies with cutting-edge technologies. "We're realizing that hair loss is a complex issue with multiple contributing factors," explains Dr. Emily Carter, a leading dermatologist specializing in hair restoration."A one-size-fits-all approach simply isn't effective. The future lies in personalized treatment plans that target the specific needs of each individual." One promising avenue involves combining topical medications with low-level laser therapy (LLLT). LLLT uses red light to stimulate hair follicles, potentially boosting the effectiveness of medications like minoxidil. Early studies suggest this combination therapy can lead to significant hair regrowth in some patients. Another exciting development is the use of platelet-rich plasma (PRP) injections. PRP, derived from the patient's own blood, is rich in growth factors that can stimulate hair follicle activity. Combining PRP with medications or LLLT may further enhance hair regrowth. While these combined therapies show promise, more research is needed to determine their long-term effectiveness and safety. However, the shift towards personalized, multi-modal approaches offers hope for those struggling with hair loss. "We're on the cusp of a new era in hair restoration," says Dr. Carter. "By combining the best of existing therapies with innovative technologies, we can offer patients more effective and personalized solutions to combat hair loss and regain their confidence." Could tiny vesicles hold the key to unlocking fuller, thicker hair? the quest for effective hair loss treatments has led to a surge in innovative solutions, from platelet-rich plasma (PRP) to growth factor concentrate (GFC). Now, a new contender is emerging: exosome therapy. While still in its early stages,this cutting-edge technology promises revolutionary advancements in hair regrowth. But how does it work, and is it ready for prime time? Exosomes are microscopic vesicles released by cells, acting as tiny messengers carrying proteins and genetic material. This unique ability makes them attractive for regenerative medicine, including hair restoration. "Exosome therapy is an exciting field with immense potential," says Dr. Bhairavi Senthil, MD, Founder and Chief Dermatologist of Dr.B 360 Dermatology Experiential Centre. "However, it's crucial to remember that this technology is still in its infancy." Safety and Efficacy: A Balancing Act While the concept of exosome therapy is captivating, several safety and efficacy concerns remain. Questions surrounding contamination,quality control,and manufacturing practices are paramount. "Good Manufacturing Practices (GMP) and rigorous regulatory compliance are essential to ensure these therapies are safe for human use," emphasizes Dr. Senthil.Some experts advocate for plant-based exosomes as a potentially safer alternative, citing lower risks of contamination compared to human-derived sources. However, more research is needed to determine their effectiveness in hair regrowth. The Personalized Medicine Revolution Looking ahead, the future of hair loss treatments lies in personalized medicine. Advances in micro-RNA research and genetic testing are paving the way for highly individualized therapies."By understanding specific pathways and deficiencies in each patient, future treatments could be tailored to deliver precise results," says Dr. Senthil. Within the next decade, experts anticipate that genetic data will play a central role in designing treatments, revolutionizing how we approach hair regrowth. The Need for Evidence-Based Research While solutions like QR678 have demonstrated their efficacy through well-documented results, exosome therapies still lack the rigorous peer-reviewed studies necessary to validate their claims. "For patients and practitioners alike, evidence-based practices remain crucial in ensuring safety, reliability, and trust in new technologies," stresses Dr.Senthil. Innovative Approaches on the Horizon The future of hair regrowth treatments is not limited to individual therapies. Exciting research explores combining solutions like QR678 with other treatments, such as autologous microcell cluster therapy or novel formulations blending peptides with plant-derived exosomes. These combinations could enhance outcomes and reduce treatment times. Additionally, alternative delivery methods, such as fractional lasers and microneedling, are being investigated to improve the efficacy of exosome-based treatments while adhering to regulatory standards. A Promising Future as we navigate the evolving landscape of hair regrowth technologies, the importance of balancing innovation with evidence cannot be overstated. Exosome therapy, though promising, requires further validation through clinical research and safety assessments.Looking ahead, the integration of advanced genetic tools and a commitment to personalized medicine may define the next generation of treatments. Hair regrowth is no longer just about restoring appearance; it's about embracing cutting-edge science to improve lives. From DNA-based treatments to AI-powered styling tools, the hair care industry is undergoing a revolution. Gone are the days of one-size-fits-all shampoos and conditioners. The future of hair care promises to be as innovative as it is indeed transformative, with technology playing a key role in delivering personalized solutions for every hair type and concern. One of the most exciting developments is the rise of DNA-based hair care.Companies are now offering tests that analyze an individual's genetic makeup to identify predispositions to hair loss, dryness, or other issues. This details can then be used to create customized hair care regimens with ingredients specifically tailored to address those needs. "Understanding your hair at a genetic level allows for truly personalized solutions," says Dr. Emily Carter, a leading dermatologist specializing in hair health. "It's like having a roadmap to your hair's unique needs." But the innovation doesn't stop there. artificial intelligence is also making its mark on the hair care industry. AI-powered styling tools are emerging, capable of analyzing hair texture and suggesting the perfect hairstyle or even guiding users through the styling process step-by-step. Imagine a hair dryer that adjusts its temperature and airflow based on your hair type, or a curling iron that learns your preferred curl pattern and automatically creates the perfect waves. These futuristic tools are no longer science fiction; they're becoming a reality. Beyond personalized treatments and styling tools, the future of hair care also emphasizes sustainability and ethical sourcing. Consumers are increasingly demanding products that are good for both their hair and the planet. This shift is driving the development of eco-kind packaging, plant-based ingredients, and cruelty-free formulations.Hair care brands are recognizing the importance of openness and ethical practices, catering to a generation of conscious consumers. The hair care industry is on the cusp of a major conversion, driven by technology, personalization, and a growing focus on sustainability.As these innovations continue to evolve, we can expect to see even more exciting developments in the years to come, promising healthier, more beautiful hair for everyone. New Delhi, India - The fight against hair loss is a global battle many are all too familiar wiht. From costly serums to surgical procedures, the quest for thicker, healthier hair has driven countless people to explore various solutions. Now, a revolutionary treatment leveraging microscopic "bubbles" called exosomes is emerging as a potential game-changer. What are Exosomes, and How Do They Work? Exosomes are naturally occurring vesicles released by cells, acting like tiny messengers carrying valuable cargo: proteins and genetic material. This inherent dialog system has sparked significant interest in regenerative medicine, showing promise for a range of applications, including hair and skin rejuvenation. "Think of exosomes as tiny packages of goodness," explains Dr. Priya Sharma, a leading dermatologist in New Delhi. "They deliver growth factors and other beneficial molecules directly to hair follicles, possibly stimulating growth and improving hair quality." Exosome Therapy: A Glimpse into the Future? While still in its early stages in India,exosome therapy is gaining traction among patients seeking non-invasive solutions for hair loss. the treatment involves injecting a concentrated solution of exosomes, derived from the patient's own cells, into the scalp. "The idea of using my own cells to promote hair growth is very appealing," says Amit Kapoor, a 35-year-old patient who recently underwent exosome therapy. "I'm hopeful that this treatment will help me regain some of the hair I've lost." A Cautious Optimism Early results are encouraging, but more research is needed to fully understand the long-term efficacy and safety of exosome therapy for hair loss. However, its potential has sparked excitement among both patients and medical professionals. "Exosome therapy represents a paradigm shift in hair restoration," emphasizes dr. Sharma. "It harnesses the body's own healing mechanisms to promote natural hair growth, offering a potentially safer and more effective alternative to traditional treatments." Beyond Exosomes: The Future of Combined Hair Loss Treatments While exosomes hold immense promise,the future of hair loss treatment likely lies in a multi-pronged approach. Scientists are exploring innovative combinations of existing therapies with cutting-edge technologies. "Hair loss is complex, with multiple contributing factors," explains Dr. Emily Carter, a leading dermatologist specializing in hair restoration. "Personalized treatment plans, targeting each individual's needs, are the future." Promising avenues include combining topical medications with low-level laser therapy (LLLT) and incorporating platelet-rich plasma (PRP) injections. These combined therapies show potential for significant hair regrowth, but more research is needed to confirm their long-term effectiveness The Take-away: The future of hair loss treatment is an exciting landscape filled with potential. While exosome therapy shows tremendous promise, it's crucial to approach it with cautious optimism. Ongoing research and rigorous safety protocols are essential to ensure these innovative treatments deliver on their potential. The coming years will likely see a shift towards personalized,multi-modal approaches,offering hope and solutions tailored to individual needs.
The Cure SMA Foundation of India has praised the government’s recent efforts to address rare diseases, including Spinal Muscular Atrophy (SMA), with over Rs 900 crore allocated for treatment procurement. The foundation urges swift action to implement the procurement process within 45 days, following the Delhi High Court’s directive. SMA, a life-threatening genetic disease, has limited treatment access in India. While the drug Risdiplam has brought hope, collaborative efforts are needed to ensure wider availability. Experts stress the importance of a holistic approach to SMA care, citing Kerala ...Read More >

Stempeutics will have to meet certain regulatory milestones, he said, as the product would be made in India and sent to Japan In a first of sorts in stem cell therapy, India's Stempeutics has inked an "option licence agreement" with Japan's Medinet, a listed company focussed on regenerative medicine - to take the former's product used in treating chronic limb threatening ischemia (CLTI), to Japan. Japan is a tough regulatory market, BN Manohar, Stempeutics Chief Executive Officer told businessl ...Read More >

Jharkhand: At least five children with thalassemia in Chaibasa tested HIV-positive on Saturday, following an investigation by a five-member medical team from Ranchi. The probe was launched after a family alleged that a local blood bank had transfused HIV-infected blood to their seven-year-old child. Officials said the child had received around 25 blood transfusions from the blood bank. District Civil Surgeon Dr. Sushanto Majhee stated the child had tested HIV-positive over a week ago and noted that HIV infection could also occur from other sources, such as contaminated needles. ALSO READ: Au ...Read More >

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a billion people affected by Non-Alcoholic Fatty Liver Disease (NAFLD) * NAFLD affects 1 in 4 people ...Read More >

New Delhi [India], September 30: When it comes to in-vitro fertilization (IVF), one of the most important factors influencing success is the quality of a woman's eggs. Healthy eggs not only improve the chances of fertilization but also increase the likelihood of developing healthy embryos that can lead to pregnancy. While age and genetics play a role, there are several steps women can take to support and enhance their egg quality before beginning an IVF cycle. At Omya Fertility, our team of specialists has over two decades of experience in helping women optimize their fertility, and we believe ...Read More >

NEW DELHI: There are several methods for removing unwanted body hair, including shaving, waxing, and threading. However, these conventional hair removal methods come with their own challenges, such as long and frequent sessions, pain, irritation, and more. With busy schedules and hectic lifestyles, people seek long-lasting grooming solutions; this is where laser hair removal comes to their rescue. Lately, laser hair removal in Delhi NCR has been rapidly gaining popularity as one of the most sought-after cosmetic procedures to get rid of unwanted body hair and enjoy silky, hair-free skin witho ...Read More >

New Delhi, Jul 8 (PTI) Apex drug regulatory body CDSCO has listed 17 drugs which should be flushed down the toilet rather than being thrown in dustbins if they have expired or are unused to help prevent harm to people and pets at home. These include tramadol, tapentadol, diazepam, oxycodone and fentanyl which may be especially harmful and in some cases fatal with just one dose if they are used by someone other than the person for whom the medicine was prescribed, the Central Drugs Standard Control Organisation (CDSCO) said. Most of these medicines are used to control pain, anxiety and other ...Read More >

A major Chinese clinical study on ovarian cancer has been published in CA: A Cancer Journal for Clinicians, one of the world's highest-impact medical journal, marking a first for a Chinese researcher-led gynecological cancer trial, researchers said in Beijing on Sunday. The phase III FZOCUS-1 study tested fluzoparib, a PARP inhibitor developed by Chinese pharmaceutical giant Hengrui Pharma. The trial evaluated the drug as a "maintenance" therapy, treatment given to prevent cancer recurrence afte ...Read More >
Thiruvananthapuram: Speaker A N Shamseer will inaugurate a two-day Kerala Cancer Conclave 2025, aimed at exploring new challenges and possibilities in cancer treatment, on Saturday in the state capital.Dr Suresh H Advani, widely regarded as the father of cancer treatment in India, will be the chief guest on the occasion. Organised under the leadership of the Association of Medical and Pediatric Oncologists of Kerala, the conclave will see participation from over 200 cancer treatment experts from within and outside the country.The event will feature discussions across seven key sessions on crit ...Read More >

Mumbai (Maharashtra) [India], March 31: Rusan Healthcare Pvt. Ltd., the marketing and distribution arm of Rusan Pharma Limited, an integrated global pharmaceutical company, has announced the launch of the multi-dose delivery pen device - APOSAN® 3ml Pen (Apomorphine Hydrochloride solution for injection in cartridge)(10mg/ml)(3ml pre-filled cartridges) for treatment of motor fluctuations commonly known as 'ON-OFF' episodes in patients suffering from Parkinson's disease (PD). Also Read | Ashok Kharat Case: 150 Women Exploited via Spiked Drinks and Hypnosis; Congress Makes Wife-Swapping Allegati ...Read More >

NEW DELHI, Apr 4 : "International Diabetes Federation" (IDF) President-elect, Dr Niti Pall, currently on India visit, called on Union Minister Dr Jitendra Singh, who is also a noted Professor of Medicine & Diabetes, and discussed, among other things, indigenous biosimilar Insulin production as well as Diabetes related indigenous biomanufacturing prospects. The meeting underscored the importance of strengthening India's capabilities in insulin manufacturing, particularly biosimilar insulins and Continuous Glucose Monitoring (CGM) instruments. The discussion brought into focus growing global c ...Read More >
Pune: Passengers on board a Goa to Pune SpiceJet flight (SG-1080) had a scare on Tuesday evening when a window panel was found dislodged while the plane was mid-air.The airline played down the incident, saying the window part that had come off was "a non-structural trim component, fitted onto the window for the purpose of shade".But a person on board the plane -- a Bombardier Q400 -- told TOI the incident triggered anxiety among the passengers. "Two to three layers of the window panel just came off," said Aatish Mishra, the passenger."There was no depressurization, but this shouldn't have happ ...Read More >

NewsVoir Ahmedabad (Gujarat) [India], September 29: As India observes World Heart Day, the conversation around cardiovascular health has once again turned to prevention, timely treatment, and most importantly, access to affordable medicines for everyone. Heart disease remains the leading cause of death in India at 28.1%, with more than half a billion people affected by a heart ailment. While treatment protocols have advanced, the cost of long-term medication continues to be a burden for many families. More so if one takes into account the fact that almost half of them cannot afford the medica ...Read More >
The Union health ministry addressed cough syrup quality. A meeting reviewed drug norm compliance. This followed child deaths linked to syrups in Chhindwara and Rajasthan. States received advice on cough syrup use for children. One cough syrup, Coldrif, contained DEG beyond limits. Action occurred against the manufacturer. Inspections began across 19 units. Officials urged adherence to manufacturing practices. Amid concerns over the quality of cough syrups, the Union health ministry on Sunday und ...Read More >
VARANASI: A team of IIT (BHU) scientists, led by Project Investigator and Assistant Professor in the Department of Biomedical Engineering, Sudip Mukherjee, is spearheading a ground-breaking initiative to develop a cell-based therapeutic platform aimed at the long-term cure of ALS (Amyotrophic Lateral Sclerosis), a fatal and debilitating neurological disorder. ALS has long posed a significant challenge to medical science. The disease, primarily of genetic origin, impacts movement, cognition, behaviour, and the overall health of individuals. In severe cases, ALS leads to respiratory failure and ...Read More >

Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world's first regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. Also Read | 'Coolie' X Review: Rajinikanth's 'One-Man Show' With Nagarjuna's Stylish Act and Anirudh Ravichander's BGM Redeems Lokesh Kanagaraj's Massy Thriller, Say Netizens. * Shilpa Medicare emerges a ...Read More >

Childhood cancer is a disease no child should ever have to face. Yet, the reality is sobering: around four lakh children worldwide are diagnosed with cancer every year, and nearly 20% of these cases come from India. Awareness is the first step to changing outcomes. This is the most common and often the hardest question to answer. Unlike adult cancers, there are no proven lifestyle or environmental factors that cause cancer in children. Nearly 90% of childhood cancers are sporadic, meaning they h ...Read More >

New Delhi: Heart disease risk calculators used across hospitals may not accurately identify Indians, who face imminent danger, states a new research involving nearly 5,000 patients. The study found that close to 80 per cent of individuals who eventually suffered a first heart attack had not been labelled 'high-risk' by widely accepted global scoring systems. These findings raise serious concerns about preventive cardiology practices in India, where heart disease often strikes earlier and progresses differently compared to Western populations. Researchers say physiological patterns, diabetes b ...Read More >

MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker ha ...Read More >

New Delhi, April 4 (SocialNews.XYZ) Union Minister Dr Jitendra Singh met with International Diabetes Federation President-elect Dr Niti Pall, and the latter highlighted that Asian and African countries "are increasingly looking to India for affordable diabetes care solutions," due to leadership in supplying cost-effective vaccines, an official statement said on Saturday. Dr Singh and Dr Pall discussed indigenous biosimilar insulin production and diabetes related indigenous biomanufacturing prospects, the Ministry of Earth Sciences said in a statement. She pointed out that high insulin prices ...Read More >
, /PRNewswire/ -- On , Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, hosted the "Data and AI: Decoding Digital Engagement" summit in , bringing together key representatives from leading Internet companies Tencent and Baidu (NASDAQ:BIDU), along with executives from over 30 leading pharmaceutical companies. They held in-depth discussions on strategies for driving user growth and enhancing business performance through innovative digital marketing solutions. The event also marked a significant expansion of Fangzhou's strategic partnerships with ...Read More >

Bhubaneswar: The Odisha government Tuesday unveiled Pharmaceutical and Medical Devices Policy-2025, aiming to attract investment of Rs 25,000 crore and create 1 lakh jobs by 2030. Chief Minister Mohan Charan Majhi launched the new policy here at the Odisha Pharma Summit-2025 in the presence of Industries Minister Sampad Chandra Swain and senior government officers. Speaking on the occasion, Industries Department's Additional Chief Secretary Hemant Sharma said India imports about 85 per cent of medical devices from other countries, and there is a huge opportunity for this sector. As a lot of ...Read More >

READ MORE: Ozempic-maker's new fat-busting drug cuts body weight by a quarter - and it comes as a jab or a PILL The Ozempic boom has seen a drug widely used to treat diabetes and manage obesity in adults transform into 'miracle' weight loss jab that's coveted by anyone with a few extra kilos to shed. Ozempic and other alternatives like Mounjaro and Wegovy are all different brand names for the drug semaglutide that mimics the the actions of GLP-1 - a hormone in the brain that regulates appetite ...Read More >

New Delhi: Apex drug regulatory body CDSCO has listed 17 drugs which should be flushed down the toilet rather than being thrown in dustbins if they have expired or are unused to help prevent harm to people and pets at home. These include tramadol, tapentadol, diazepam, oxycodone and fentanyl which may be especially harmful and in some cases fatal with just one dose if they are used by someone other than the person for whom the medicine was prescribed, the Central Drugs Standard Control Organisation (CDSCO) said. Most of these medicines are used to control pain, anxiety and other conditions. S ...Read More >

The car had a Maharashtra number plate. Luggage was tied to the roof of the vehicle, which made officials believe that a family had come from Maharashtra to visit Agra. A shocking and heartbreaking incident has come to light from the Taj Mahal complex in Agra, Uttar Pradesh. An elderly man was found unconscious and tied inside a locked car parked near the western gate. The incident has raised serious questions about human sensitivity and responsibility. According to Aaj Tak, the man had been locked inside the car for several hours. The extreme heat and humidity had made his condition critic ...Read More >

Mumbai, Oct 31 (SocialNews.XYZ) Actress Deepika Padukone, who has been a strong advocate for mental health awareness, reacted to cricketer Jemimah Rodrigues' recent revelation about battling anxiety. The 'Om Shanti Om' actress, known for openly sharing her own struggles with depression in the past, praised Jemimah for her honesty and courage in speaking up, highlighting the importance of conversations around mental well-being in sports and beyond. Taking to her Instagram Stories, Deepika Padukone reshared a video of cricketer Jemimah Rodrigues, in which the athlete opened up about her struggl ...Read More >

BusinessWire India Bengaluru (Karnataka) [India], March 31: CRLAB ties up with Hairline International to bring next-gen non-surgical hair replacement to India. This strategic partnership comes at a time when hair loss has become increasingly prominent in the country. Studies indicate that nearly 60% of men and 40% of women experience some form of hair loss during their lifetime. These numbers were earlier associated with the 35-50 age group. Today, younger individuals are also reporting similar concerns. This shift is changing how people approach hair restoration. Many consumers now prefer s ...Read More >

New Delhi [India], March 30: Hair has always been a significant part of the personality of celebrities and Bollywood actors. People have been copying the hairstyles of their favorite stars, whether it's Rajesh Khanna, Amitabh Bachchan, Salman Khan, or anyone else. An impressive hairstyle adds to an actor's powerful on-screen presence. But even actors and celebrities have to face hair loss and baldness issues at some point in their lives. While many actors like Rajinikanth and Akshaye Khanna use hair patches or wigs in their films, some actors choose a permanent solution in the form of a celebr ...Read More >
New Delhi, Jan 27 (PTI) An analysis of blood samples of children and teenagers with long Covid has revealed a "distinct protein signature in plasma", which researchers say can help develop a blood test for diagnosis. Long Covid refers to the symptoms, including chronic fatigue, that persist despite recovering from acute COVID-19 infection. The condition, including causes, treatments and diagnostics, continues to be studied around the world. Researchers, including those from the Catholic University of Milan, Italy, have analysed the blood samples of 112 youngsters aged under 19 years -- 34 ha ...Read More >

Marathahalli Police arrested Dr. Mahendra Reddy for allegedly murdering his wife, dermatologist Dr. Kruthika M Reddy, by administering anaesthetic drugs. Six months after the death of a 29-year-old dermatologist from Bengaluru, Marathahalli Police have arrested the victim's husband, a fellow doctor, for allegedly murdering his wife by injecting anaesthetic drugs, police said on Wednesday. Meanwhile, the family of Kritika has accused her husband, Mahendra, of foul play, alleging he was involved in an extra-marital affair and had been giving her unnecessary medications and drips. "We had susp ...Read More >